SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-040293
Filing Date
2023-03-31
Accepted
2023-03-31 17:12:58
Documents
13
Period of Report
2023-03-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2311113d1_8k.htm   iXBRL 8-K 30489
2 EXHIBIT 10.1 tm2311113d1_ex10-1.htm EX-10.1 17884
  Complete submission text file 0001104659-23-040293.txt   230893

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mrns-20230331.xsd EX-101.SCH 3048
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mrns-20230331_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mrns-20230331_pre.xml EX-101.PRE 22605
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2311113d1_8k_htm.xml XML 3739
Mailing Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087
Business Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087 484-801-4670
MARINUS PHARMACEUTICALS, INC. (Filer) CIK: 0001267813 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36576 | Film No.: 23789109
SIC: 2834 Pharmaceutical Preparations